Skip to content

Effectiveness of a positive expiratory pressure device after heart valve replacement surgery

EFFICACY OF USING PEP DEVICE FOLLOWING HEART VALVE REPLACEMENT SURGERY - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/106386
Enrollment
34
Registered
2026-03-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I089- Rheumatic multiple valve disease,unspecified

Interventions

Intervention1: Pep: This group will receive PEP device along with breathing exercises and spirometer. These training will be given 5 days per week for 4 weeks. The Forced Expiratory Volume in 1 secon

Sponsors

Narayana Hrudayalaya Institute of Physiotherapy
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients 20-45 years undergoing heart valve replacement surgery (aortic, mitral, tricuspid, or pulmonary valve replacement). 2. Hemodynamically stable post-surgery and able to participate in physiotherapy interventions. 3. No pre-existing severe pulmonary conditions (e.g., moderate to severe COPD, interstitial lung disease) that could confound the study results. 4.No contraindications to using a PEP device (e.g., facial trauma, unstable airways). 5. Ability to provide informed consent and follow study procedures. 6. Undergoing standard postoperative care including early mobilization and respiratory physiotherapy.

Exclusion criteria

Exclusion criteria: Presence of postoperative complications such as severe hemodynamic instability, excessive bleeding, or sternal dehiscence that prevent active participation. Pre-existing neuromuscular disorders affecting respiratory function Known or suspected active respiratory infections (e.g., tuberculosis, COVID-19) that could impact the efficacy of PEP therapy. Severe cognitive impairment or inability to follow instructions (e.g., advanced dementia, delirium).

Design outcomes

Primary

MeasureTime frame
FEV1 AND PEFRTimepoint: Baseline and end of 4 weeks intervention

Secondary

MeasureTime frame
Reduction in postoperative pulmonary complications and improvement in airway clearanceTimepoint: Baseline and end of 4 weeks interventions

Countries

India

Contacts

Public ContactDr Deepak JainN

Narayana Hrudayalaya Institute of Physiotherapy

ndjk2011@gmail.com9731036223

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026